Thanks! You've successfully subscribed to the BONEZONE®/OMTEC® Monthly eNewsletter!

Please take a moment to tell us more about yourself and help us keep unwanted emails out of your inbox.

Choose one or more mailing lists:
BONEZONE/OMTEC Monthly eNewsletter
OMTEC Conference Updates
Advertising/Sponsorship Opportunities
Exhibiting Opportunities
* Indicates a required field.

Executive Interview: Michael E. Miller, Chief Executive Officer, Orchid Orthopedic Solutions

Michael E. MillerIn 1990, Mike Miller combined his experience in exotic alloy manufacturing with his love for automobile racing and formed Stealth Technologies. With just five employees, Miller quickly established Stealth as a key supplier of high-performance auto parts to some of the top racing teams and engine parts distributors in the U.S. At the same time, groundwork was being laid to enter the business of supplying complex net-shape forgings to the orthopaedic implant industry. Miller was instrumental in introducing these near-net forgings to the medical industry.

During this initial period, Miller was invited by one of the major orthopaedic implant supply companies to serve on a planning committee. The committee was formed to explore the possibility of using near-net shape forging technology to replace the gross forging technology that was currently being used in manufacturing orthopaedic implants.

Almost immediately Stealth became a major supplier in the implant forging business, with medical revenues that were quickly surpassing automotive. The intervening years have been marked by several noteworthy events. In 2001, Stealth acquired Hy-Vac Medical Technologies in Collierville, Tennessee, a company that specializes in porous coating of implants. In 2003, the Biomaterials Division of Astro-Met was purchased to merge with Stealth’s coating division and place the company as a leader in orthopaedic porous coating.

Orchid Orthopedic Solutions, LLC was formed in 2005 when Churchill Equity Partners acquired majority ownership of Stealth Medical Technologies, Unique Instruments, Unique Design, Bio Coat and Bio Vac. In 2005, Mike Miller was named Chief Executive Officer of Orchid.

MACDEE was the next acquisition in 2006, adding precision machined and molded plastics to Orchid’s array of capabilities. In 2007, Orchid merged with another fund of companies that Churchill owned. These included Micro Precision Swiss, Keller Engineering and Anzon. Orchid Orthopedic Solutions now employs more than 1,000 people at its various locations, and Mr. Miller continues as the CEO today.

BONEZONE: Tell us about Orchid.

Mike Miller: Orchid is a full solution provider focused on the orthopaedic market. We help companies bring their products to market by utilizing our vast and varied capabilities in both design and manufacturing. This is done through our management of the entire value stream of the product or, if the customer prefers, using our services à la carte to enhance their own internal manufacturing and design.

Our specific manufacturing capabilities include forging, turning, milling, grinding, EDM, color coding, laser marking, TiN coating, diamond coating, passivation, gun drilling, injection molding, laser cutting and welding, assembly, sterile and non-sterile packaging, titanium plasma spray coating, hydroxyl apatite coating, sintered bead coating, specialty coatings and resorbable blast media surface treatments.

Our design services include computer aided engineering, prototyping, pre-clinical testing, quality and regulatory consulting, broad concept development, thorough feasibility confirmation, innovative design services, qualification testing and validation protocol writing.


Security code